Clinical trial
Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia
NCT00212381 · New York Presbyterian Hospital, Other · Completed
Key facts
| NCT number | NCT00212381 |
|---|---|
| Title | Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia |
| Official title | Diindolylmethane (DIM) Dietary Supplementation: A Nonsurgical Treatment for Cervical Intraepithelial Neoplasia (CIN) |
| Lead sponsor | New York Presbyterian Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Cervical Dysplasia |
| Intervention type | Dietary Supplement, Drug |
| Interventions | di indolylmethane (DIM), Red rice bran |
| Enrollment | 62 |
| Start date | Sep 1, 2000 |
| Primary completion | Jan 1, 2006 |
| Completion | Jul 1, 2010 |
| First posted | Sep 21, 2005 |
| Last update posted | Mar 29, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: